Margaret Fahnestock - Concepedia

Author

Margaret Fahnestock

Also Known As

Camilla Michalski, Fahnestock, Margaret, M FAHNESTOCK, M Fahnestock, M L Fahnestock, M. Fahnestock, M.L. Fahnestock, MARGARET FAHNESTOCK, Margaret Fahnestock, Margaret Fahnestock,

201

Publications

12.2K

Citations

H-Index

191

Concepts

All Affiliations

McMaster University University of Toronto

About

Margaret Fahnestock is an author at McMaster University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	72	6.3K
2	Health Sciences	17	18	1.4K
3	Natural Sciences	5	5	256
4	Engineering	3	3	112
5	Education	2	2	176

Margaret Fahnestock

109

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication Přemysl Berčík, A. J. Park, D. Sinclair, Neurogastroenterology & Motility	2011	989
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity Fabia Filipello, Raffaella Morini, Irene Corradini, Immunity InflammationMedicineSynaptic TransmissionSynapse EliminationImmunology	2018	693
Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease Shiyong Peng, Joanne Wuu, Elliott J. Mufson, Journal of Neurochemistry	2005	688
The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease Margaret Fahnestock, Bernadeta Michalski, Bin Xu, Molecular and Cellular Neuroscience Neurodegenerative DiseasesPredominant FormAlzheimer's DiseaseNeuroanatomyNerve Growth Factor	2001	482
Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease R. M. Damian Holsinger, Jane Schnarr, Pauline Henry, Molecular Brain Research Alzheimer's DiseaseBdnf MrnaDecreased LevelsNeurochemical BiomarkersNeurology	2000	324
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s disease Bernadeta Michalski, Margaret Fahnestock Molecular Brain Research Parietal CortexNeurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseBrain Function	2003	251
Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease Shiyong Peng, Joanne Wuu, Elliott J. Mufson, Journal of Neuropathology & Experimental Neurology NeuropsychologyNeurochemical BiomarkersAlzheimer's DiseaseNeurologyAging-associated Disease	2004	232
Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease Shiyong Peng, Diego J. Garzon, Monica Marchese, Journal of Neuroscience Transgenic Mouse ModelsNeurochemical BiomarkersSocial SciencesAlzheimer's DiseaseLarge Oligomers	2009	214
Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Glenda MacQueen, Karuna Ramakrishman, Susan D. Croll, Behavioral Neuroscience Molecular NeuroscienceStress HormonePsychiatryBehavioral NeuroscienceNeurophysiology	2001	185
Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells Diego J. Garzon, Margaret Fahnestock Journal of Neuroscience	2007	183

Page 1